BRCA1 and breast neoplasm: Subsequently, we compared molecular, clinical, and epigenetic characteristics associated with the BRCA1-like phenotype, restricting our analyses to hormone-receptor-positive breast cancer (i.e. breast tumors expressing estrogen receptor (ER), progesterone receptor (PR), and/or human epidermal growth factor receptor 2 (HER2).